X
AVNS icon

Xponance’s Avanos Medical AVNS Stock Holding History

Xponance’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,307
Closed -$232K – 1249
2021
Q1 		$232K Sell
5,307
-1,035
-16% -$48.6K ﹤0.01% 1010
2020
Q4 		$291K Sell
6,342
-21
-0.3% -$874 0.01% 957
2020
Q3 		$211K Buy
+6,363
New +$203K 0.01% 969

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Xponance's AVNS Position: Q2 2021 in Review

Xponance sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 5,307 shares — an estimated $232K sold.

Xponance first reported a position in AVNS in Q3 2020 and held it in 3 quarters. The position peaked at $291K in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • Xponance reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • Xponance sold 5,307 Avanos Medical shares in Q2 2021, an estimated $232K.
  • Xponance first reported a position in Avanos Medical in Q3 2020 and held it in 3 quarters.
  • Xponance's Avanos Medical position peaked at $291K in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Xponance's 13F filing for Q2 2021, filed 12 Aug 2021.